| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911352 | Lung Cancer | 2012 | 5 Pages |
Abstract
In patients with SCLC metabolic activity determined using 18FDG-PET (SUVmax) differed between stage I-III and stage IV diseases. Compared to NSCLC, the relationship between SUVmax and prognosis seems more complex.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
C. van der Leest, E.F. Smit, J. Baas, R.J. Versteijlen, N. van Walree, H.C. Hoogsteden, J.G.J.V. Aerts,